Fidelity Investments
IDYA icon

Fidelity Investments’s IDEAYA Biosciences IDYA Stock Holding History

Fidelity Investments’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$526M Buy
14,109,431
+937,328
+7% +$28.7M 0.02% 533
2026
Q1 		$439M Buy
13,172,103
+22,143
+0.2% +$743K 0.02% 563
2025
Q4 		$455M Buy
13,149,960
+3,415
+0% +$109K 0.02% 549
2025
Q3 		$358M Buy
13,146,545
+9,251
+0.1% +$224K 0.02% 626
2025
Q2 		$276M Buy
13,137,294
+6,800
+0.1% +$130K 0.02% 693
2025
Q1 		$215M Buy
13,130,494
+167,343
+1% +$3.57M 0.01% 770
2024
Q4 		$333M Buy
12,963,151
+327,498
+3% +$9.27M 0.02% 621
2024
Q3 		$400M Buy
12,635,653
+1,365,570
+12% +$51.8M 0.02% 555
2024
Q2 		$396M Buy
11,270,083
+1,114,829
+11% +$44.1M 0.03% 531
2024
Q1 		$446M Buy
10,155,254
+9,267,045
+1,043% +$398M 0.03% 494
2023
Q4 		$31.6M Sell
888,209
-209,032
-19% -$6.24M ﹤0.01% 1463
2023
Q3 		$29.6M Buy
1,097,241
+343
+0% +$8.7K ﹤0.01% 1449
2023
Q2 		$25.8M Buy
1,096,898
+515,379
+89% +$10.6M ﹤0.01% 1539
2023
Q1 		$7.98M Buy
581,519
+24,369
+4% +$406K ﹤0.01% 1961
2022
Q4 		$10.1M Sell
557,150
-216,515
-28% -$3.64M ﹤0.01% 1884
2022
Q3 		$11.5M Buy
773,665
+148,436
+24% +$1.93M ﹤0.01% 1836
2022
Q2 		$8.63M Sell
625,229
-367,245
-37% -$4.08M ﹤0.01% 2029
2022
Q1 		$11.1M Sell
992,474
-327,116
-25% -$4.82M ﹤0.01% 2074
2021
Q4 		$31.2M Buy
1,319,590
+958,586
+266% +$22.3M ﹤0.01% 1616
2021
Q3 		$9.2M Buy
361,004
+316,288
+707% +$7.39M ﹤0.01% 2163
2021
Q2 		$939K Buy
44,716
+44,589
+35,109% +$916K ﹤0.01% 2671
2021
Q1 		$3K Buy
+127
New +$2.45K ﹤0.01% 3643

Other funds holding IDYA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments's IDYA Position: Q2 2026 in Review

Fidelity Investments increased its IDEAYA Biosciences (IDYA) stake by 7.1% in Q2 2026, buying an estimated $28.7M and bringing the position to 14,109,431 shares worth $526M. The position accounts for 0.02% of the portfolio, ranked #533.

Fidelity Investments first reported a position in IDYA in Q1 2021 and has held it in 22 quarters since. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Fidelity Investments held 14,109,431 shares of IDEAYA Biosciences worth $526M as of Q2 2026.
  • Fidelity Investments bought 937,328 IDEAYA Biosciences shares in Q2 2026, an estimated $28.7M.
  • IDEAYA Biosciences made up 0.02% of Fidelity Investments's portfolio in Q2 2026, its #533 holding.
  • Fidelity Investments first reported a position in IDEAYA Biosciences in Q1 2021 and has held it in 22 quarters since.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.